The vitamin D-induced calcium-binding protein calbindin-D (CaBP) was localized immunohistochemically in some but not all of the cell bodies and axons within the intestinalis nerve of the chicken. Unlike other nerve tissue thus far examined, the CaBP content of the intestinalis nerve was decreased in vitamin D deficiency and increased in chicken adapted to a calcium-deficient diet. These changes are qualitatively similar to the pattern of response of enterocytes. The inclusion of calcium-containing solutions within the duodenal lumen caused, directly or indirectly, a decrease in the amount of CaBP in this nerve in a dose-dependent manner. The exact role of CaBP in intestinalis nerve cells is unknown but may be in the regulation of intracellular ionic Ca2+ concentrations during excitation, although other functions of CaBP cannot be excluded. CaBP occurs in two general forms, the avian type of Mr -28,000 and with four high-affinity calcium-binding sites (Ka, '-2 x 106 M-1) and the mammalian type of Mr -9,000 and with two high-affinity binding sites (2). These proteins are homologous with calmodulin and other members of the troponin C superfamily of calcium-binding proteins.
The induction of the synthesis of the calcium-binding protein calbindin-D (CaBP) in intestine, kidney, and certain other tissues has been shown to be dependent on the seco-steroid vitamin D or its biologically active metabolites (1, 2) . In severe vitamin D deficiency, the CaBP content of intestinal mucosa is virtually absent and is considerably decreased in renal tissue (2) . However, brain CaBP does not change in vitamin D deficiency and remains essentially the same as in the normal vitamin D-replete animal (3) . Based on such observations, a relationship between the rate of cell turnover and the rate of decrease of CaBP content with the onset of vitamin D deficiency in a particular tissue was suggested.
CaBP occurs in two general forms, the avian type of Mr -28,000 and with four high-affinity calcium-binding sites (Ka, '-2 x 106 M-1) and the mammalian type of Mr -9,000 and with two high-affinity binding sites (2) . These proteins are homologous with calmodulin and other members of the troponin C superfamily of calcium-binding proteins.
The concentration of CaBP in intestinal mucosa is wellcorrelated with the transport of calcium across the epithelial cell barrier and is considered to increase the transfer of calcium from the microvillar region to the basal-lateral membrane (4, 5) , as well as possibly having other functions in the transport process (6) . CaBP has been localized immunohistochemically in certain cells of the brain and central nervous system, such as the Purkinje cells of the cerebellum, the hippocampus, and cells of sensory systems (7) (8) (9) (10) (11) (12) (13) (14) (15) . Although its function therein is unknown, CaBP may play a role in the management of intracellular calcium ion concentrations. Calcium ions are known to subserve various functions of the nervous system, including the release of neurotransmitter, the stimulation of calcium-calmodulin-dependent protein kinases, the operation of calcium-dependent potassium channels, and, from studies with invertebrates, the possible involvement in such processes as habituation and sensitization (16, 17 1To whom reprint requests should be addressed.
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Ultrasonics, Plainview, NY), and centrifuged at 30,000 x g for 1 hr at 40C. The supernate was recovered and analyzed for CaBP by a radioimmunoassay using 125I-labeled CaBP, essentially as described by McCann et al. (19) . Purified standard CaBP was isolated from chicken duodenum as described (20) .
Electrophoretic Mobility of CaBP from Duodenal and Nervous Tissue. The mesenteric tissue and cerebellar tissue from 4-week-old vitamin D-repleted chicken were prepared as described above in Tris buffer mixture and centrifuged at 30,000 x g for 30 min. Aliquots of the supernate were disassociated by incubating at 370C for 30 min in 1% NaDodSO4/2% 2-mercaptoethanol/0.2% Tris; purified duodenal CaBP was similarly treated. These samples, singly or in combination, were subjected to electrophoresis on NaDodSO4/polyacrylamide slab gels (21) . The resolved proteins were electrophoretically transferred to nitrocellulose sheets (pore size, 0.45 Am; Millipore), essentially as described by Towbin et al. (22) . The electrophoretic blots were incubated in a solution composed of 10% fetal bovine serum/3% bovine serum albumin in the Tris buffer mixture for 2 hr at 370C. The membrane was rinsed in Tris-buffered saline (20 mM Tris-HCI/Q.5 M NaCl, pH 7.5). After incubating with rabbit anti-chicken CaBP antiserum diluted in Tris-buffered saline overnight at 20'C-220C, the blot was thoroughly rinsed. The blot was then incubated for 2 hr at 20'C-220C with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Cappel Laboratories, Cochranville, PA) diluted 1:100 in the Tris buffer mixture containing 10% fetal bovine serum and 3% bovine serum albumin and was then thoroughly rinsed again in Tris-buffered saline. For color development, the Bio-Rad HRP Color Development Kit was used.
Radial Diffusion Immunoassay for CaBP in Duodenal Mucosa. CaBP in the mucosa of the duodenum was determined by a radial immunodiffusion assay as described (3) .
Protein Analysis. The protein concentrations of the mucosal and mesenteric tissue were determined by the procedure of Lowry et al. (23) , using bovine serum albumin as the standard protein.
Effect of Vitamin D Deficiency. One-day-old chicks were fed a rachitogenic diet for 4 weeks. One half of the chicks were given 500 international units (IU) of vitamin D3 in 0.2 ml of propylene glycol intramuscularly 72 hr before the experiment. The other half received propylene glycol only. Concentrations of CaBP in the duodenal mucosa and the intestinalis nerve associated with caudal mesentery vessels were determined as indicated above.
Effect of Adaptation to Calcium-Deficient Diet. One-day-old chicks were fed a commercial chick starter diet (Agway, Ithaca, NY) for 3 weeks and subsequently divided into three groups of five or six chickens per group. The groups were then fed complete diets that varied only in calcium content and contained either 0.1%, 1.0%, or 2.0% calcium. Each diet contained 0.67% phosphorus and 1200 IU of vitamin D3 per kg of diet. After 8 days on these diets and an overnight fast, the chickens were killed and the duodenum and mesenteric tissue were excised for CaBP analysis.
Effect of Intraluminal Calcium and Calcium Absorption. Vitamin D-repleted chickens were anesthetized with ether and the duodenum was exposed. Solutions containing NaCl (150 mM) and 45CaC12 (1 pACi/ml; 1 Ci = 37 GBq) (pH 7.2), with the total calcium concentration ranging from 1 to 40 mM, were injected into the duodenal lumen (1 ml per chicken), using the in situ ligated loop procedure as described (24, 25) . Chickens were anesthetized 15 min later, blood was withdrawn from the mesenteric vein draining the duodenum, and 45Ca in the venous serum was quantified using a liquid scintillation counter (Beckman). The mesenteric tissue was then excised and analyzed for CaBP by radioimmunoassay as noted above.
RESULTS
Immunohistochemical Localization. After the presence of immunologically reactive CaBP had been demonstrated in the mesenteric tissue, the localization of CaBP was determined immunohistochemically (26) . CaBP was not present in the endothelial cells or in the smooth muscle cells of the mesenteric vein and artery, but was found in nerve cell bodies and axons of the intestinalis nerve, a nerve anatomically associated with these vessels (Fig. 1) . It can be seen that only some of the nerve cells in the ganglion contained CaBP. This is reminiscent of other nerve tissues-e.g., the brain-in which only specific neuronal cells were shown to contain CaBP (7) (8) (9) (10) (11) (12) (13) (14) (15) . CaBP was also visualized in axons and specifically associated with axonal varicosities.
Radioimmunoassay and Immunoblot. In validating the radioimmunoassay procedure, it was shown that serial dilu- (Fig. 2) . The slopes of these two curves were not different, indicating that the reactive compound in the intestinalis nerve was immunologically identical to CaBP purified from the duodenum. Furthermore, the immunoblot (Fig. 3) showed that the immunoreactive proteins in the nerve and cerebellar preparations have essentially the same electrophoretic mobility as purified chicken intestinal CaBP. The protein in cerebellum appears as a doublet, suggesting heterogeneity of CaBP in this tissue. Previously, Pochet et al. (27) reported the presence of two CaBPs in rat brain, with apparent molecular weights of 27,000 and 29,000. A very faint protein band above the denser band in the intestinalis nerve extract also suggests the possible presence of two CaBPs in this peripheral nerve.
Effect of Vitamin D Deficiency. The CaBP content of the intestinalis nerve varied significantly with various treatments, as did duodenal CaBP. As shown in Table 1 (25, 28, 29) , and the CaBP associated with the nerve was also significantly less in those animals consuming the normal (1%) and high (2%) calcium diets as compared to the animals in the low calcium (0.1%) group.
Effect of Intraluminal Calcium and Calcium Absorption. Depicted in Fig. 4 B, same as lane A + CaBP; C, CaBP; D, cerebellum + CaBP; E, cerebellum. The immunoreactive material in each preparation migrated on the NaDodSO4 gels essentially the same as purified CaBP.
A doublet was apparent in the cerebellar extract, which suggests multiple forms of the brain protein.
intestinalis nerve in response to intraluminal calcium. When the calcium content of the solution injected into the duodenal lumen was 10 mM or greater, the CaBP content of the intestinalis nerve decreased significantly. The absorption of calcium from the various calcium-containing solutions was calculated from the specific activity of 45Ca in precursor compartment (duodenal lumen) and the 45Ca in venous blood, and these data are also shown in Fig. 4 .
DISCUSSION
CaBP, discovered in the intestinal mucosa, has been localized in a number of tissues and organs of chickens, including the central nervous system and sensory nerves (7) (8) (9) (10) (11) (12) (13) (14) (15) . Unlike the intestine, the CaBP content of the brain is not diminished in the vitamin D-deficient state and remains essentially the same as in brains of vitamin D-replete chickens (3). However, Taylor (30) demonstrated an increase in the CaBP concentration in brain tissue when vitamin D was chronically administered to rachitic chickens. The only other manipulation shown to affect brain CaBP was the production of epileptic rats by way of the "kindling" procedure, a procedure in which electrical impulses are delivered to the brain at periodic intervals over a number of days (31) ; in this situation, the depletion of CaBP-like immunoreactivity was localized to the dentate granule cell-mossy fiber system of the hippocampus. Siegel et al. (32) also reported that the direct injection of pharmacological doses of 1,25-dihydroxyvitamin D3 into the brain increased the resistance of "kindled" rats to epileptic-like episodes. This effect of 1,25-dihydroxyvitamin D3 on seizure activity occurred rapidly (within 5-10 min), was transient, and is probably too rapid in onset to be manifested by new protein synthesis. Large doses of vitamin D were also shown to decrease the number of seizures in epileptic patients without concomitant changes in serum calcium and magnesium concentrations (33) . In the present study, it was demonstrated that the concentration of CaBP in the intestinalis nerve associated with the caudal mesentery vein and artery was significantly lower in vitamin D-deficient chickens than in the vitamin D-replete chickens. However, in contrast to the rachitic duodenal mucosa, which was virtually devoid of CaBP in the severely vitamin D-deficient chicken, the intestinalis nerve still contained CaBP. The difference in the response of the two tissues to vitamin D deficiency could be due to differences in the rate of cell turnover and/or the longevity of the CaBP mRNA and/or the rate of release of CaBP.
Restriction of the dietary intake of calcium is a known stimulus for increased production of 1,25-dihydroxyvitamin D3 by the renal 25-hydroxyvitamin D-la-hydroxylase enzyme system (34, 35) . As was reported by us (25) and others (28, 29) the group receiving the 0.1% calcium diet was greater by =340% when compared to the 2% dietary calcium group and the increase in nerve CaBP was =280%.
Of interest and indeed unexpected was the response of CaBP in the intestinalis nerve to a pulse of calcium placed in the duodenal lumen. The CaBP content of the nerve tissue decreased substantially 15 min after solutions containing 10 mM or more of calcium were deposited in the duodenal lumen. The precise stimulus for the decrease of CaBP under these circumstances is unknown but might be due to a transient hypercalcemia or, indirectly, the secretion of intestinal hormones, such as cholecystokinin and pentagastrin; the latter hormones are known affectors of calcitonin release in some species (36) . Perhaps related to these observations is the report that adrenocorticotropic hormone and insulin (via the resultant hypoglycemia) caused an increase in CaBP in plasma of pigs (37) , indicating an effect of certain hormones on the release of CaBP from intracellular sites. Although the primary source of blood CaBP seems to be the intestinal mucosa (38, 39) , other CaBP-containing tissues, such as nerve cells, could constitute another source.
The calcium ion plays a significant role in physiological and biochemical processes in nerve tissue. As is known, calcium is required for neurotransmitter release and activates, with calmodulin, such processes as ATP-dependent calcium transport, phosphorylation ofneuronal proteins, glycogenolysis, and neurotransmitter synthesis. The calcium that participates in such reactions could be derived from extracellular sources, entering neuronal tissue through potential and/or receptoroperated calcium channels, or from internal stores. The presence of CaBP in specific neurons might exert important effects on the control of neuronal function through its ability to bind calcium with high affinity and thereby control intracellular Ca2+ levels by essentially serving as a calcium buffer, as suggested by Baimbridge et al. (40) . The resting free Ca2' concentration in most cells is considered to be 10-7 M and CaBP, with a dissociation constant of -0.5 x 10-7 M, could influence intracellular free Ca2' levels in this capacity. The buffer function of CaBP could place a constraint on the excessive increase in intracellular Ca2+ upon agonist stimulation or depolarization, or it could maintain intracellular Ca2' levels at stimulatory concentrations over a longer period of time than in its absence. It is also possible that neuronal CaBP has other functions since there is evidence that the Mr 28,000 CaBP from chicken intestine and the Mr 9000 CaBP from bovine intestine can stimulate the activity of the intestinal basolateral ATPdependent calcium pump (6, 41, 43) .
The physiological and pathological implications of the dependency of CaBP in the intestinalis nerve on calcium and vitamin D status cannot be defined from current data. However, a relationship between calcium, vitamin D intake, and hypertension in certain individuals has been reported (42) . The possibility exists that CaBP in peripheral nerve might modulate smooth muscle contractility, thereby determining the degree of vascular resistance and, as a consequence, regional blood flow and blood pressure. It would be of interest, therefore, to determine whether CaBP is present in peripheral nerves of humans and, if so, its dependency on vitamin D and calcium status.
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